BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29190982)

  • 1. Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.
    Park J; Choi Y; Namkung J; Yi SG; Kim H; Yu J; Kim Y; Kwon MS; Kwon W; Oh DY; Kim SW; Jeong SY; Han W; Lee KE; Heo JS; Park JO; Park JK; Kim SC; Kang CM; Lee WJ; Lee S; Han S; Park T; Jang JY; Kim Y
    Oncotarget; 2017 Nov; 8(54):93117-93130. PubMed ID: 29190982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.
    Chan A; Prassas I; Dimitromanolakis A; Brand RE; Serra S; Diamandis EP; Blasutig IM
    Clin Cancer Res; 2014 Nov; 20(22):5787-95. PubMed ID: 25239611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic model for pancreatic cancer using a multi-biomarker panel.
    Choi YJ; Yoon W; Lee A; Han Y; Byun Y; Kang JS; Kim H; Kwon W; Suh YA; Kim Y; Lee S; Namkung J; Han S; Choi Y; Heo JS; Park JO; Park JK; Kim SC; Kang CM; Lee WJ; Park T; Jang JY
    Ann Surg Treat Res; 2021 Mar; 100(3):144-153. PubMed ID: 33748028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma.
    Park HD; Kang ES; Kim JW; Lee KT; Lee KH; Park YS; Park JO; Lee J; Heo JS; Choi SH; Choi DW; Kim S; Lee JK; Lee SY
    Proteomics; 2012 Dec; 12(23-24):3590-7. PubMed ID: 23065739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Kim H; Kang KN; Shin YS; Byun Y; Han Y; Kwon W; Kim CW; Jang JY
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32492943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma.
    Yeo I; Kim GA; Kim H; Lee JH; Sohn A; Gwak GY; Lee JH; Lim YS; Kim Y
    Hepatol Commun; 2020 May; 4(5):753-768. PubMed ID: 32363324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.
    Song J; Sokoll LJ; Chan DW; Zhang Z
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling.
    Guo X; Lv X; Fang C; Lv X; Wang F; Wang D; Zhao J; Ma Y; Xue Y; Bai Q; Yao X; Chen Y
    Int J Cancer; 2016 Oct; 139(8):1821-9. PubMed ID: 27281120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients.
    Peng H; Pan S; Yan Y; Brand RE; Petersen GM; Chari ST; Lai LA; Eng JK; Brentnall TA; Chen R
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone.
    Haab B; Qian L; Staal B; Jain M; Fahrmann J; Worthington C; Prosser D; Velokokhatnaya L; Lopez C; Tang R; Hurd MW; Natarajan G; Kumar S; Smith L; Hanash S; Batra SK; Maitra A; Lokshin A; Huang Y; Brand RE
    bioRxiv; 2024 May; ():. PubMed ID: 38826212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma.
    Cao YY; Guo K; Zhao R; Li Y; Lv XJ; Lu ZP; Tian L; Ren S; Wang ZQ
    Digit Health; 2023; 9():20552076231179007. PubMed ID: 37312938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker Development for Intraductal Papillary Mucinous Neoplasms Using Multiple Reaction Monitoring Mass Spectrometry.
    Kim Y; Kang M; Han D; Kim H; Lee K; Kim SW; Kim Y; Park T; Jang JY; Kim Y
    J Proteome Res; 2016 Jan; 15(1):100-13. PubMed ID: 26561977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein.
    Chen J; Wu W; Chen L; Zhou H; Yang R; Hu L; Zhao Y
    Pancreatology; 2013; 13(3):290-7. PubMed ID: 23719603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
    Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
    Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics.
    Lindahl A; Heuchel R; Forshed J; Lehtiö J; Löhr M; Nordström A
    Metabolomics; 2017; 13(5):61. PubMed ID: 28413374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
    Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
    Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.
    Tang H; Partyka K; Hsueh P; Sinha JY; Kletter D; Zeh H; Huang Y; Brand RE; Haab BB
    Cell Mol Gastroenterol Hepatol; 2016 Feb; 2(2):201-221.e15. PubMed ID: 26998508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZFHX3 methylation in peripheral blood monocytes as a potential biomarker for pancreatic cancer detection.
    Li Y; Fan Z; Meng Y; Yang J; Li P; Liu S; Pang C; Du L; Wang Y; Zhan H
    Pancreatology; 2024 Jun; ():. PubMed ID: 38853072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.